The Johnson & Johnson Innovation has launched the applications for Global Health Discovery QuickFire Challenge: Flavivirus Infections that aims to advance scientific discoveries to help treat, control, or prevent flaviviruses with the goal of tackling the next global public health threat.
Working together, they can spark the next great idea that could change the trajectory of health.
Johnson & Johnson is committed to helping address the dual gap in innovation and health equity through the establishment of the J&J Centers for Global Health Discovery (J&J CGHD). This global network of research collaborations and partnerships brings together their talent and expertise with that of leading academic institutions with the aim to stimulate and speed up the early-stage research and development needed to address entrenched and emerging pandemic threats.
- Grant funding from a total pool of $300,000.
What they’re looking for
- They are interested in potentially ground-breaking ideas aiming to treat, control, or prevent flavivirus disease, such as:
- Exploratory therapeutic platform technologies targeting the genus Flavivirus (or Flavivirdae family)
- Broad-spectrum therapeutics/antiviral modalities targeting viral replication of flaviviruses (dengue virus, Zika virus, West Nile virus, Japanese Encephalitis virus, yellow fever virus)
- Immune-mediated approaches such as host-directed targets aiming to control flavivirus infections
- Disease learning: understanding underlying mechanism of flavivirus pathogenesis
- Novel approaches toward patient identification and stratification that can include:
- Multidimensional biomarker discovery platforms, including those with AI/ML based analytics
- Deep patient clinical and molecular phenotyping data sets
- Enabling technologies for clinical trials:
- Potential solutions aiming to identify and recruit specific patient sub-populations.
- Potential solutions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:
- Potential impact on human health
- Uniqueness and level of innovation of the idea
- Feasibility of the idea and potential path to commercialization
- Thoroughness of approach
- Identification of key resources and plan to further ideate
- Rapid implementation and deployability with the potential to reach patients in communities most vulnerable to flavivirus diseases
- Applicants must have a physical presence in Asia, Australia, or Oceania.
For more information, visit https://jnjinnovation.com/innovation-challenges/global-health-discovery-quickfire-challenge-flavivirus-infections